Skip to main content
. 2020 Mar 26;6:GO.20.00014. doi: 10.1200/GO.20.00014

FIG 2.

FIG 2

Three-year overall survival (and 95% CI) from oropharynx cancer by human papillomavirus (HPV) type 16 status in the InterCHANGE study (2011-2017).